Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 1999American Journal of Clinical Oncology

Phase II Trial of the Combination of Paclitaxel and 5-Fluorouracil in the Treatment of Advanced Gastric Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAndré M. MuradUniversidade Federal de Minas GeraisAPAndy PetroianuUniversidade Federal de Minas GeraisRGRodrigo C. Guimarães

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murad et al. (1999) studied this question.

synapsesocial.com/papers/6a882fd8b98a632b5e4fcdd7https://doi.org/10.1097/00000421-199912000-00008
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer1993 · 790 citations
  2. 2Activity of Taxol in Patients With Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus1994 · 289 citations
  3. 3Nonparametric Estimation from Incomplete Observations1958 · 7,786 citations
  4. 4Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.1991 · 393 citations
  5. 5A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin1985 · 394 citations